| Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model J Fernandez-Gomez, R Madero, E Solsona, M Unda, L Martinez-Piñeiro, ... The Journal of urology 182 (5), 2195-2203, 2009 | 638 | 2009 |
| Prognostic factors in patients with non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials J Fernandez-Gomez, E Solsona, M Unda, L Martinez-Piñeiro, M Gonzalez, ... European urology 53 (5), 992-1002, 2008 | 273 | 2008 |
| multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin … A Ojea, JL Nogueira, E Solsona, N Flores, JM Gómez, JR Molina European Urology 52 (5), 1398-406, 2007 | 261 | 2007 |
| Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of … JÉA MartÍNez-PiÑEiro, L Martínez-Piñeiro, E Solsona, RHÁN RodrÍGuez, ... The Journal of urology 174 (4 Part 1), 1242-1247, 2005 | 211 | 2005 |
| The EORTC tables overestimate the risk of recurrence and progression in patients with non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external … J Fernandez-Gomez, R Madero, E Solsona, M Unda, L Martinez-Piñeiro, ... European urology 60 (3), 423-430, 2011 | 205 | 2011 |
| Maintenance therapy with 3-monthly bacillus Calmette-Guérin for 3 years is not superior to standard induction therapy in high-risk non–muscle-invasive urothelial bladder … L Martínez-Piñeiro, JA Portillo, JM Fernández, JA Zabala, I Cadierno, ... European urology 68 (2), 256-262, 2015 | 89 | 2015 |
| Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non–muscle-invasive bladder cancer in … E Solsona, R Madero, V Chantada, JM Fernandez, JA Zabala, JA Portillo, ... European urology 67 (3), 508-516, 2015 | 77 | 2015 |
| Club Urologico Espanol de Tratamiento Oncologico (CUETO). Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 … JA Martinez-Pineiro, L Martinez-Pineiro, E Solsona, RH Rodríguez, ... J Urol 174 (4 Pt 1), 1242-7, 2005 | 60 | 2005 |
| Stromal factors involved in human prostate cancer development, progression and castration resistance N Eiro, J Fernandez-Gomez, R Sacristán, B Fernandez-Garcia, B Lobo, ... Journal of cancer research and clinical oncology 143, 351-359, 2017 | 54 | 2017 |
| Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer M Alvarez-Múgica, V Cebrian, JM Fernández-Gómez, F Fresno, S Escaf, ... The Journal of urology 184 (4), 1507-1513, 2010 | 44 | 2010 |
| Matrix metalloproteinases and bladder cancer: what is new? O Rodriguez Faba, J Palou-Redorta, JM Fernández-Gómez, F Algaba, ... International Scholarly Research Notices 2012, 2012 | 43 | 2012 |
| Club Urológico Español de Tratamiento Oncológico (CUETO). Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin … J Fernandez-Gomez, E Solsona, M Unda, L Martinez-Piñeiro, M Gonzalez, ... Eur Urol 53 (5), 992-1001, 2008 | 38 | 2008 |
| Peripheral neuropathy: an underdiagnosed cause of erectile dysfunction C Valles‐Antuña, J Fernandez‐Gomez, F Fernandez‐Gonzalez BJU international 108 (11), 1855-1859, 2011 | 31 | 2011 |
| Club Urológico Español de Tratamiento Oncológico. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer … J Fernandez-Gomez, R Madero, E Solsona, M Unda, L Martinez-Piñeiro, ... Eur Urol 60 (3), 423-30, 2011 | 30 | 2011 |
| Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guérin Response in Patients with High-grade Non–muscle-invasive Bladder Carcinoma M Alvarez-Mugica, JM Fernandez-Gomez, V Cebrian, F Fresno, S Escaf, ... European urology 63 (2), 364-370, 2013 | 29 | 2013 |
| Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC) M Álvarez-Maestro, F Guerrero-Ramos, O Rodríguez-Faba, ... Actas Urológicas Españolas (English Edition) 45 (2), 93-102, 2021 | 28 | 2021 |
| Treatment trends for clinically localized prostate cancer. National population analysis: GESCAP group B Miñana, A Rodríguez-Antolín, F Gómez-Veiga, C Hernández, JF Suárez, ... Actas Urológicas Españolas (English Edition) 40 (4), 209-216, 2016 | 22 | 2016 |
| Predictive factors for impaired renal function following nephroureterectomy in upper urinary tract urothelial cell carcinoma O Rodríguez Faba, J Palou, A Breda, P Maroto, JM Fernández Gómez, ... Urologia Internationalis 92 (2), 169-173, 2014 | 22 | 2014 |
| An alternative technique to prevent obturator nerve stimulation during lateral bladder tumours transurethral resection JG Rodríguez, AJ Monzón, RCG Alvarez, CA Laso, JMF Gomez, ... Actas urologicas espanolas 29 (5), 445-447, 2005 | 22 | 2005 |
| Sympathetic skin response in patients with erectile dysfunction C Valles‐Antuña, J Fernandez‐Gomez, S Escaf, F Fernandez‐Gonzalez BJU international 104 (11), 1709-1712, 2009 | 20 | 2009 |
